Session 6 - Innovating molecular diagnostic technologies for the clinic

Tuesday, 21 April, 2015 - 08:30 to 10:00


Tania Bubela
Tania Bubela
University of Alberta

This session will explore challenges in late-stage molecular diagnostics development, current best practices and strategies for enabling innovation in molecular diagnostics and personalized medicine. Stakeholder perspectives related to IP protection, technology transfer, investment, commercialization and health care system adoption will be shared and discussed, including both private- and public-sector views. To allow for interactive discussion between the panel members and the audience, the session will be run with minimal time devoted to formal presentations.

Session Evaluation